Healthcare Innovation Fund Expression of Interest Process October 2022
BHF is seeking innovative proposals for improving services for patients with cardiovascular disease. The expressions of interest (EoIs) range from problem statements to ready-to-test solutions. Round one submission deadline is on December 5th, 2022. Criteria include unmet clinical problems, consensus among multidisciplinary teams, scalability, and lead applicant being a registered clinical professional employed by an NHS organization. Visit slide 7 for the EoI form and slide 8 for exclusion criteria.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Healthcare Innovation Fund Expression of Interest Process October 2022
Contents 1 2 3 4 5 Types of EoI and Criteria Exclusion Criteria Introduction Process EoI Form Links to Expression of Interest (EoI) forms Outline of the process associated with each type of EoI Overview of the programme Overview of the type and the criteria Signposting to other BHF funding streams Timeline 2
1. Introduction BHF is seeking to test and evaluate innovative approaches to the delivery of improved services for patients with cardiovascular disease. We are seeking expressions of interest for proposals ranging in scale of maturity from a problem statement that is yet to be defined through to ideas/solutions that are ready to be tested. BHF will work with the applicants to co-develop ideas/solutions so that they are suitable for implementation funding. We are seeking expressions of interest (EoIs) for round one from October 12th 2022 until 09.00am on December 5th 2022, so that ideas can be explored in the next quarter with a view towards implementation funding being awarded at a later stage. The process and funding amounts are set out on slides 5 and 6. The link to the EoI form is on slide 7 along with the timeline for assessment. Exclusion criteria are provided on slide 8. 3
2. Types of EoI 2 1 Problem scoped, potential solution(s) to be tested Problem to be scoped Please note that all criteria must be met 1. An unmet clinical problem that impacts the provision of services for patients with any type of cardiovascular disease 2. There is consensus among a multidisciplinary team (MDT) that services need to be developed or redesigned to address the clinical problem 3. The intended impact is an improvement in patient outcome 4. The intended solution must be scalable. 5. There is a clearly articulated agreement supporting the need to explore a solution now (e.g.it is an emerging clinical situation with no specific pathway tested, no other funder is addressing it, the clinical issue is increasing in scale, severity, or urgency). 6. The lead applicant must be a registered clinical professional and employed by an NHS organisation Please note that all criteria must be met 1. Scoping has already been carried out, by an MDT, of an unmet clinical problem that impacts the provision of services for patients with any type of cardiovascular disease 2. There is a consensus among the MDT on the potential solution(s) that should be tested. 3. The MDT included service users (patients, family, carers). 4. The intended impact is an improvement in patient outcome 5. The solution to be tested must be scalable in principle. 6. There is a clearly articulated agreement supporting the need to test the implementation of potential solutions now 7. The intervention(s) to be tested is/are not established practice in other parts of the UK already. 8. The lead applicant must be a registered clinical professional and employed by an NHS organisation Criteria A relatively new classification of a disease (e.g. HFpEF) where standardised clinical practice, based on medical research outcomes, have yet to be agreed or established nationally. There needs to be consensus amongst the MDT on which service level issues need to be addressed and on the types of ideas that could be implemented. An MDT has developed a consensus statement on a significant clinical issue (for example, The Shock to Survival report on cardiogenic shock) with recommendations for future clinical practice. Ideas that are not already established practice could be worked up as a fundable proposal for testing in more than one clinical setting. Examples 4
3.Process, outputs and scale of funding 1 2 Problem to be scoped and potential solutions to be identified Problem already scoped, potential solution(s) to be tested Process 1. 2. Complete an EoI If approved by BHF, proceed to delivery of outputs within agreed timescales May progress to stage 2 following delivery of the outputs below 1. 2. 3. Complete an EoI If approved by BHF, proceed to delivery within agreed timescales May progress to implementation funding following delivery of the outputs below 3. Outputs Workshops or meetings to discuss the implementation of the proposed solution(s) and the evaluation methodology b) Co-development of criteria for implementation and evaluation c) Once the proposal is fully worked up, applicants can apply for implementation funding (process to be determined later). a) a) b) Co-development of the problem statement and potential solution(s) Workshops or meetings to discuss the issue with a multidisciplinary team Scale of funding 10K maximum to support workshops for scoping and co-development of problem statement and identification of potential solutions 10k maximum to support co-development of criteria for implementation of solution; 5
4.Implementation funding The process for awarding implementation funding to selected EoI applicants will be discussed at a later stage once the proposal has been worked up the required standard. Funding will range from 50K to 300K to test the implementation of worked up proposals and will be subject to a formal application for funding to be assessed by peer reviewers. Further information on this process will be shared later as we work with selected applicants. 6
5. Application process Complete an Expression of Interest form 6. Timeline Completed forms for round one will assessed on December 5th 2022. Deadlines for subsequent rounds of funding will be communicated later in the year. October 2022 Nov 2022 Dec 2022 Jan 2023 Feb 2023 March 2023 April 2023 May 2023 June 2023 July 2023 Aug 2023 Sept 2023 The EoI process is open Launch Assessment of EoI forms from Dec 5th 2022 Assessment Process to award funding for implementation of selected proposals Working up ideas to fundable proposals to be tested Delivery 7
7. Exclusion criteria This fund cannot be used to fund biomedical research, such as a clinical trial. Please see the full range of BHF s funding schemes for medical research The fund can only be used to improve services where the focus of that service is to treat people with cardiovascular disease. Funding will not be awarded for projects where the NHS is already awarding funding (please check the NHS funding programmes available within each nation before applying). If you d like an informal chat about the process or your idea, please contact healthcareinnovation@bhf.org.uk 8
